Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

A Study of AZD0120 in Autoimmune Diseases

NCT07295847

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Stanford, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Ann Arbor, Michigan, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

NCT06655155

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Arizona Arthritis and Rheumatology Associates Phoenix, Arizona, United States
  • UCLA Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Illinois Health Outpatient Care Center Chicago, Illinois, United States
View all 76 locations
View Trial Details
Recruiting

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

NCT07115745

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Brigham And Womens Hospital Boston, Massachusetts, United States
  • Duke University Durham, North Carolina, United States
  • Local Institution - 0007 Camperdown, New South Wales, Australia
  • Local Institution - 0008 Brisbane, Queensland, Australia
View all 28 locations
View Trial Details

Related conditions